Composition for therapeutic and cosmetic botulinum toxin
US7459164B2 · kind B2 · utility
7Cited by
11References
18Claims
0Family size
Assignee
Inventor
Key dates
| Filing date | May 28, 2003 |
| Grant date | Dec 2, 2008 |
| Priority date | — |
| Expiry date | Jul 5, 2025 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K2800/59
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
This invention relates to a composition of botulinum based pharmaceuticals used for therapeutic and cosmetic treatment. This invention offers an improvement on the prior art by eliminating the potential of blood-borne contamination with botulinum based pharmaceuticals. Recombinant serum albumin is taught for use in the place of human serum albumin as a stabilizing or enhancing agent.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.